Hahné Susan J M, Charlett André, Purcell Bernadette, Samuelsson Susanne, Camaroni Ivonne, Ehrhard Ingrid, Heuberger Sigrid, Santamaria Maria, Stuart James M
National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
BMJ. 2006 Jun 3;332(7553):1299-303. doi: 10.1136/bmj.332.7553.1299.
To review the evidence for effectiveness of treatment with antibiotics before admission in reducing case fatality from meningococcal disease.
Systematic review.
Cochrane register of trials and systematic reviews, database of abstracts of reviews of effectiveness, health technology assessment, and national research register in England and Wales, Medline, Embase, and CAB Health.
Studies describing vital outcome of at least 10 cases of meningococcal disease classified by whether or not antibiotics were given before admission to hospital.
14 observational studies met the review criteria. Oral antibiotic treatment given before admission was associated with reduced mortality among cases (combined risk ratio 0.17, 95% confidence interval 0.07 to 0.44). In seven studies in which all included patients were seen in primary care, the association between parenteral antibiotics before admission and outcome was inconsistent (chi2 for heterogeneity 11.02, P = 0.09). After adjustment for the proportion given parenteral antibiotics before admission, there was no residual heterogeneity. A higher proportion of patients given parenteral antibiotics before admission was associated with reduced mortality after such treatment and vice versa (P = 0.04).
Confounding by severity is the most likely explanation both for the beneficial effect of oral antibiotics and the harmful effect observed in some studies of parenteral antibiotics. We cannot conclude whether or not antibiotics given before admission have an effect on case fatality. The data are consistent with benefit when a substantial proportion of cases are treated.
回顾入院前使用抗生素治疗以降低脑膜炎球菌病病死率的有效性证据。
系统评价。
Cochrane试验注册库及系统评价、疗效评价摘要数据库、卫生技术评估、英格兰和威尔士国家研究注册库、Medline、Embase及CAB Health。
描述至少10例脑膜炎球菌病患者重要转归的研究,根据入院前是否使用抗生素进行分类。
14项观察性研究符合评价标准。入院前给予口服抗生素治疗与患者死亡率降低相关(合并风险比0.17,95%置信区间0.07至0.44)。在7项所有纳入患者均在初级保健机构就诊的研究中,入院前给予肠外抗生素与转归之间的关联不一致(异质性卡方值11.02,P = 0.09)。在对入院前接受肠外抗生素治疗的比例进行校正后,不存在残余异质性。入院前接受肠外抗生素治疗的患者比例越高,此类治疗后的死亡率越低,反之亦然(P = 0.04)。
严重程度的混杂因素最有可能解释口服抗生素的有益作用以及在一些肠外抗生素研究中观察到的有害作用。我们无法得出入院前使用抗生素是否对病死率有影响的结论。当大部分病例接受治疗时,数据显示存在益处。